Saxony Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $458K | Buy |
2,467
+226
| +10% | +$42K | 0.35% | 62 |
|
|
2025
Q1 | $470K | Buy |
2,241
+101
| +5% | +$21.2K | 0.41% | 54 |
|
|
2024
Q4 | $380K | Buy |
2,140
+436
| +26% | +$77.5K | 0.33% | 68 |
|
|
2024
Q3 | $336K | Sell |
1,704
-692
| -29% | -$137K | 0.31% | 84 |
|
|
2024
Q2 | $411K | Sell |
2,396
-1
| -0% | -$171 | 0.45% | 61 |
|
|
2024
Q1 | $437K | Sell |
2,397
-52
| -2% | -$9.47K | 0.53% | 50 |
|
|
2023
Q4 | $380K | Buy |
+2,449
| New | +$380K | 0.5% | 53 |
|